Dr Esther Camp-Dotlic
Post-doctoral Researcher / Lecturer
School of Biomedicine
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Esther has a research background in progenitor cell biology, migration and differentiation during development and tissue remodelling in vertebrates. She joined the Mesenchymal Stem Cell Research Group in 2013 after having worked as a post-doctoral scientist in Australia, Spain and the UK. Her work at SAHMRI is focused on understanding the molecular mechanisms that control mesenchymal stem/progenitor cell (MSC) proliferation and differentiation during cranial development. The projects she is developing include; investigating the role of the transcription factor Twist-1 and microRNAs in skeletal bone derived MSC and cranial cells, in addition to how these factors can lead to cranial defects in children. She also leads a number of pre-clinical trials that look at the efficiency and safety of drugs to prevent abnormal cranial suture fusion. A better understanding of how cranial defects occur will enable the development of new therapeutic strategies to alleviate abnormal cranial bone formation in children.
-
Language Competencies
Language Competency English Can read, write, speak, understand spoken and peer review Spanish; Castilian Can read, write, speak and understand spoken -
Education
Date Institution name Country Title The University of Adelaide Australia PhD
-
Journals
-
Conference Papers
Year Citation 2018 Camp, E., Anderson, P., Zannettino, A., & Gronthos, S. (2018). Inhibition of tyrosine kinase receptor C-ROS-1 as a novel treatment for patients with TWIST haploinsufficiency induced craniosynostosis. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 33 (pp. 424). Montreal, CANADA: WILEY. 2005 Camp-Dotlic, E., Froiland, D., Kind, K., Irving-Rodgers, H., Thompson, J., & Russell, D. (2005). Murine HIF-1a localisation by immunohistochemistry in a mouse reproductive tissue. In Reproduction Fertility and Development Vol. 17 (pp. 129). C S I R O Publishing.
National Health and Medical Research Council- Histone Demethylase KDM6 is a novel target for treating craniosynostosis in children with Saethre-Chotzen Syndrome(2018-2020).
National Health and Medical Research Council- Tyrosine Kinase receptor c-ros-oncogene 1 mediates TWIST-1 haploinsufficiency induced craniosynostosis in children: A novel therapeutic target (2017-2019).
Channel 7 Children's Research Foundation of SA Inc, Identification of TWIST-1 regulated microRNAs which control cranial bone development in children (2015).
British Society of Developmental Biology Travel Grant (2011).
John and Pamela Salter Charitable Trust Grant UK (2010).
MYORES Exchange Fund grant. MYORES: European Muscle Development Network (2009).
Cellular and Systems Neurobiology
Physiology 2A, 2B
Principles of Human Health and Disease
Biology of Disease
Dental Science and Practice 1 Part 1
Human Biology IOH Part 2
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2018 Co-Supervisor KDM6A, a Histone Demethylase, as a Novel Therapeutic Target for Treating Craniosynostosis in Children with Saethre-Chotzen Syndrome (SCS) Doctor of Philosophy Doctorate Full Time Miss Clara Pribadi -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2016 - 2019 Co-Supervisor Identification of Molecular Mechanisms Mediating TWIST-1 Regulation of Mesenchymal Stem Cell Proliferation and Differentiation Doctor of Philosophy Doctorate Full Time Mr Chee Ho H'ng -
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2017 - 2017 Co-Supervisor Targeting Tyrosinase Kinase Receptor C-ROS-Oncogene 1 to reduce aberrant osteogenesis in Twist-1 haploinsufficiency induced craniosynostosis The University of Adelaide Honours Full Time Gabrielle Fusco-Allison
Connect With Me
External Profiles
